Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Rasagiline 1 mg Tablets (Remedica vs Azilect) in Healthy Adult Thai Volunteers under Fasting
TCTR20251022003Phase 2Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Mar 2026
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rasagiline, sponsored by International Bio Service. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
rasagiline
Beyond the preview
Go deeper on TCTR20251022003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251022003.